230 related articles for article (PubMed ID: 33726782)
1. Gamma heavy chain disease associated with rheumatoid arthritis: a case report.
Danic G; Dejoie T; Caillon H; Achille A; Pottier P; Agard C
J Med Case Rep; 2021 Mar; 15(1):121. PubMed ID: 33726782
[TBL] [Abstract][Full Text] [Related]
2. Gamma-heavy chain monoclonal gammopathy with undetermined significance (MGUS).
Zushi Y; Sasaki M; Saitoh T; Aoyama Y; Gotoh Y; Tsunemine H; Kodaka T; Okamura A; Takahashi T
J Clin Exp Hematop; 2019 Sep; 59(3):119-123. PubMed ID: 31391403
[TBL] [Abstract][Full Text] [Related]
3. Rheumatoid arthritis associated with transient gamma 2-heavy chain disease.
Ockhuizen T; Smit JW; van Leeuwen M
Rheumatol Int; 1983; 3(4):167-72. PubMed ID: 6422533
[TBL] [Abstract][Full Text] [Related]
4. Gamma heavy chain disease in a patient with rheumatoid arthritis--a laboratory evaluation.
Johannis W; Blommer J; Klatt AR; Renno JH; Wielckens K
Biochem Med (Zagreb); 2012; 22(3):373-9. PubMed ID: 23092068
[TBL] [Abstract][Full Text] [Related]
5. Gamma heavy-chain disease accompanied with follicular lymphoma: a case report.
San-José P; Aguadero V; Perea G; Estrada M; Berlanga E
Biochem Med (Zagreb); 2018 Feb; 28(1):010802. PubMed ID: 29472805
[TBL] [Abstract][Full Text] [Related]
6. [Heavy chain diseases].
Seligmann M
Rev Prat; 1993 Feb; 43(3):317-20. PubMed ID: 8502962
[TBL] [Abstract][Full Text] [Related]
7. Gamma heavy chain disease (γ-HCD) as iatrogenic immunodeficiency- associated lymphoproliferative disorder: Possible emergent subtype of rheumatoid arthritis-associated γ-HCD.
Tsunemine H; Zushi Y; Sasaki M; Nishikawa Y; Tamura A; Aoyama Y; Kodaka T; Itoh T; Takahashi T
J Clin Exp Hematop; 2019; 59(4):196-201. PubMed ID: 31866621
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma and multiple plasmacytomas associated with free gamma heavy chain, free kappa light chain and IgGk paraproteins: an unusual triple gammopathy.
Deighan WI; O'Kane MJ; McNicholl FP; Keren DF
Ann Clin Biochem; 2016 Nov; 53(6):706-711. PubMed ID: 27166317
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal free light chains can be found in heavy chain diseases.
López-Anglada L; Puig N; Díez-Campelo M; Alonso-Ralero L; Barrena S; Aparicio MA; Gutiérrez NC; García-Sanz R
Ann Clin Biochem; 2010 Nov; 47(Pt 6):570-2. PubMed ID: 20930031
[TBL] [Abstract][Full Text] [Related]
10. Gamma heavy chain disease complicated by pulmonary hypertension, which was successfully treated with lenalidomide.
Shibata S; Fukunaga A
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33257362
[TBL] [Abstract][Full Text] [Related]
11. Chronic arthritis and gamma heavy chain disease: coincidence or pathogenic link?
Husby G; Blichfeldt P; Brinch L; Brandtzaeg P; Mellbye OJ; Sletten K; Stenstad T
Scand J Rheumatol; 1998; 27(4):257-64. PubMed ID: 9751465
[TBL] [Abstract][Full Text] [Related]
12. A case report: isolated a heavy chain monoclonal gammopathy in a patient with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin change syndrome.
Kim SK; Park IK; Park BH; Park W; Lee HS; Kim TH; Jun JB; Bae SC; Yoo DH; Uhm WS
Int J Clin Pract Suppl; 2005 Apr; (147):26-30. PubMed ID: 15875614
[TBL] [Abstract][Full Text] [Related]
13. Long-term renal survival of γ3-heavy chain deposition disease: a case report.
Katsuno T; Mizuno S; Mabuchi M; Tsuboi N; Komatsuda A; Maruyama S
BMC Nephrol; 2017 Jul; 18(1):239. PubMed ID: 28716013
[TBL] [Abstract][Full Text] [Related]
14. [Gamma heavy chain disease associated with rheumatoid arthritis. Spontaneous disappearance of the pathologic protein].
Gaucher A; Bertrand F; Brouet JC; Pourel J; Netter P; Faure G; Seligmann M
Sem Hop; 1977 Nov; 53(38):2117-20. PubMed ID: 204020
[TBL] [Abstract][Full Text] [Related]
15. Heavy chain disease.
Witzig TE; Wahner-Roedler DL
Curr Treat Options Oncol; 2002 Jun; 3(3):247-54. PubMed ID: 12057070
[TBL] [Abstract][Full Text] [Related]
16. Case records of the Massachusetts General Hospital. Case 13-2008. A 46-year-old man with rheumatoid arthritis and lymphadenopathy.
Munshi NC; Digumarthy S; Rahemtullah A
N Engl J Med; 2008 Apr; 358(17):1838-48. PubMed ID: 18434654
[No Abstract] [Full Text] [Related]
17. Sequential development of Waldenström's macroglobulinemia and gamma-1-heavy chain disease in a single patient. Clinical, immunochemical, immunofluorescent and protein studies.
Ockhuizen T; Jilderda JF; Cazemier T
Acta Haematol; 1984; 71(1):53-9. PubMed ID: 6419527
[TBL] [Abstract][Full Text] [Related]
18. Heavy chain diseases.
Wahner-Roedler DL; Kyle RA
Best Pract Res Clin Haematol; 2005; 18(4):729-46. PubMed ID: 16026747
[TBL] [Abstract][Full Text] [Related]
19. Tubulointerstitial nephritis accompanying gamma-heavy chain deposition and gamma-heavy chain restricted plasma cells in the kidney.
Nayer A; Green DF; Gonzalez-Suarez ML; Sujoy V; Ikpatt OF; Thomas DB
Iran J Kidney Dis; 2014 Sep; 8(5):417-23. PubMed ID: 25194410
[TBL] [Abstract][Full Text] [Related]
20. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
